However, GLP-1R ablation in PVN does not affect glucose metabolism and the vagus nerve is implicated in the effects of peripherally administered GLP-1 on food intake and glycaemia (21)
Clinicians should monitor thyroid function tests (TSH, free T4) at: Baseline before starting weight loss injections 6-8 weeks after achieving maintenance dose Every 3-6 months during active weight loss After significant weight stabilization Symptoms of overreplacement (palpitations, anxiety, tremor, heat intolerance) should prompt earlier testing
Coordinate multidisciplinary care among endocrinologists, obstetricians, and reproductive specialists to optimize timing of therapy and transition
You cannot separate them by drawing differently
Sattar N, Lee MM, Kristensen SL, Branch KR, Del Prato S, Khurmi NS, et al